GUELPH, ON, Nov. 15, 2022 /CNW/ - BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced its results for the three and nine-month periods ended September 30, 2022. Biorem's complete third quarter financial statements and MD&A have been filed on SEDAR (www.sedar.com).
Read more at newswire.ca
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.
